HomeOrganizations › CHILDRENS CANCER THERAPY DEVELOPMENT INSTITUTE

CHILDRENS CANCER THERAPY DEVELOPMENT INSTITUTE

OR · EIN 465759569

5
Executives Disclosed
$2.4M
Annual Revenue
$2.8M
Total Assets

CHILDRENS CANCER THERAPY DEVELOPMENT INSTITUTE has 5 executives with disclosed compensation. The highest-paid executive, Charles Keller (Science Dir.), received peak total compensation of $345,572.


Top Executive Compensation Over Time


Executive Compensation

Name Title Peak Comp. Latest Comp. Years vs. Household
Charles Keller Science Dir. $346K $346K 2017–2025 4.6x
Molly Lindquist PAST EXEC DIR $104K $0 2019–2020 1.4x
Claire Newman Executive Dir. $78K $0 2025–2025 1x
Jason McGill DIRECTOR OF FIN $46K $0 2020–2022 0.6x
Lisa Price EXEC ADMIN $41K $0 2021–2024 0.6x

Annual Summary

Year Executives Avg. Comp. Highest Comp. Total Payroll
2017 1 $0 $0 $0
2018 1 $0 $0 $0
2019 2 $177K $177K $177K
2020 3 $177K $177K $177K
2021 3 $191K $191K $191K
2022 3 $210K $210K $210K
2023 2 $221K $221K $221K
2024 2 $338K $338K $338K
2025 2 $346K $346K $346K
Email Alerts

Get notified about CHILDRENS CANCER THERAPY DEVELOPMENT INSTITUTE

Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.